Advertisement

Natural Products pp 2559-2580 | Cite as

Nutraceuticals and Antioxidants in Prevention of Diseases

  • Neelam Jain
  • Kishan G. RamawatEmail author
Reference work entry

Abstract

Drugs and food from natural origin play an important role in public health-care system throughout the world. The word nutraceutical is a broad term describing foods, food ingredients, and dietary supplements that provide specific health or medical benefits, in addition to the basic nutritional value found in the food. A significant source for nutraceutical ingredients is bioactive phytochemicals like alkaloids, various terpenoids, and polyphenols (anthocyanins, flavones, flavanols, isoflavones, stilbenes, ellagic acid, etc.). A variety of these phytochemical compounds form an integral part of the nutraceutical market being antioxidants, and they help in the prevention of many degenerative and chronic diseases. In this review, classification of nutraceuticals, phytochemical classes as nutraceutical ingredients, antioxidants as nutraceuticals, and advantages and drawbacks along with nutraceutical market development are discussed.

Keywords

Antioxidants dietary supplements functional foods nutraceuticals phytochemicals 

Abbreviations

CAGR

Compound annual growth rate

FMCG

Fast-moving consumer goods

ROS

Reactive oxygen species

Notes

Acknowledgements

This work was supported by financial assistance from UGC-DRS under special assistance program for medicinal plant research to K.G.R. N. J. thanks UGC for financial assistance in the form of fellowship.

References

  1. 1.
    Esther B (2000) What is nutraceutical? Pharm J 265:57–58Google Scholar
  2. 2.
    De Felice SL (1995) The nutraceutical revolution, its impact on food industry. Trends Food Sci Technol 6:59–61CrossRefGoogle Scholar
  3. 3.
    Jack DB (1995) Keep taking the tomatoes – the exciting world of nutraceuticals. Mol Med Today 1:118–121CrossRefGoogle Scholar
  4. 4.
    Brower B (1998) Nutraceuticals: poised for a healthy slice of the market. Nat Biotechnol 16:728–733CrossRefGoogle Scholar
  5. 5.
    Mannion M (1998) Nutraceutical revolution continues at foundation for innovation in medicine conference. Am J Nat Med 5:30–33Google Scholar
  6. 6.
    Pandey M, Verma RK, Saraf SA (2010) Nutraceuticals: new era of medicine and health. Asian J Pharm Clin Res 3:11–15Google Scholar
  7. 7.
    Kalra EK (2003) Nutraceutical-definition and introduction. AAPS Pharm Sci 5:2–3CrossRefGoogle Scholar
  8. 8.
    Ferrari CKB (2004) Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology 5:275–289CrossRefGoogle Scholar
  9. 9.
    Ross S (2000) Functional foods: the food and drug administration perspective. Am J Clin Nut (Suppl) 71:1735S–1738SGoogle Scholar
  10. 10.
    Bagchi D (2006) Nutraceuticals and functional foods regulations in the United States and around the world. Toxicology 221:1–3CrossRefGoogle Scholar
  11. 11.
    Brighenti F, Casiraghi MC, Canzi E, Ferrari A (1999) Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr 53:726–733CrossRefGoogle Scholar
  12. 12.
    Roberts DCK et al (1994) The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre. Med J Aust 161:600–664Google Scholar
  13. 13.
    Hendriks HF, Weststrate JA, van Vliet T, Meijer GW (1999) Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53:319–327CrossRefGoogle Scholar
  14. 14.
    Hardy G (2000) Nutraceuticals and functional foods: introduction and meaning. Nutrition 16:688–689CrossRefGoogle Scholar
  15. 15.
    Agriculture: A Glossary of Terms, Programs, and Laws, 2005 Edition, Jasper Womach, Coordinator Congressional Research Service, The Library of Congress (http://www.cnie.org/NLE/CRSreports/05jun/97-905.pdf)
  16. 16.
    Ramawat KG, Dass S, Mathur M (2009) The chemical diversity of bioactive molecules and therapeutic potential of medicinal plants. In: Ramawat KG (ed) Herbal drugs: ethnomedicine to modern medicine. Springer, Berlin/HeidelbergCrossRefGoogle Scholar
  17. 17.
    Zulak KG, Liscombe DK, Ashihara H, Facchini PJ (2006) Alkaloids. In: Crozier A, Clifford M, Ashihara H (eds) Plant secondary metabolism in diet and human health. Blackwell, OxfordGoogle Scholar
  18. 18.
    Dillard CJ, German JB (2000) Phytochemicals: nutraceuticals and human health. J Sci Food Agric 80:1744–1756CrossRefGoogle Scholar
  19. 19.
    Beltz LA (2009) The effects of the green tea polyphenol epigallocatechin gallate on the central nervous, endocrine, and innate immune systems. In: Ramawat KG (ed) Herbal drugs: ethnomedicine to modern medicine. Springer, Berlin/HeidelbergGoogle Scholar
  20. 20.
    Polat U (2010) The effects on metabolism of glucosinolates and their hydrolysis products. J Biol Environ Sci 4:39–42Google Scholar
  21. 21.
    Donovan JL, Manach C, Faulks RM, Kroon PA (2006) Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashihara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell, Oxford, UKGoogle Scholar
  22. 22.
    Traka M, Mithen R (2009) Glucosinolates, isothiocyanates and human health. Phytochem Rev 8:269–282CrossRefGoogle Scholar
  23. 23.
    McIntyre BS, Briski KP, Gapor A, Sylvester PW (2000) Anti proliferative and apoptotic effects of tocopherols and tocotrienols in preneoplastic and neoplastic mammary epithelial cells. Proc Soc Exp Biol Med 224:292–301CrossRefGoogle Scholar
  24. 24.
    Watzl B, Bub A, Briviba K, Rechkemmer G (2003) Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men. Ann Nutr Metab 47:255–261CrossRefGoogle Scholar
  25. 25.
    Bendich AJ (1989) Carotenoids and the immune response. J Nutr 119:112–115Google Scholar
  26. 26.
    Jian L, Du C-J, Lee AH, Binns CW (2005) Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer 113:1010–1014CrossRefGoogle Scholar
  27. 27.
    Hertog MGL, Feskens EJM, Hollman PCH, Katan JB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342:1007–1011CrossRefGoogle Scholar
  28. 28.
    Dorow P, Weiss T, Felix R, Schmutzler H (1987) Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease. Arzneimittelforschung 37:1378–1381Google Scholar
  29. 29.
    Quilez J, Garcia-Lorda P, Salas-Salvado J (2003) Potential uses and benefits of phytosterols in diet: present situation and future directions. Clin Nutr 22:343–351CrossRefGoogle Scholar
  30. 30.
    Bouic PJD (2001) The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr Opin Clin Nutr Metab Care 4:471–475CrossRefGoogle Scholar
  31. 31.
    Crozier A, Clifford MN, Ashihara H (eds) (2006) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell, Oxford, UKGoogle Scholar
  32. 32.
    Crozier A, Yokota T, Jaganath IB, Marks S, Saltmarsh M, Clifford MN (2006) Secondary metabolites in fruits, vegetables, beverages and other plant-based dietary components. In: Crozier A, Clifford MN, Ashihara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell, Oxford, UKCrossRefGoogle Scholar
  33. 33.
    Strack D (1997) Phenolic metabolism. In: Dey PM, Harborne JB (eds) Plant biochemistry. Academic, London, UKGoogle Scholar
  34. 34.
    Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043CrossRefGoogle Scholar
  35. 35.
    Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y, Swarts M, Yang S, Zhang SB, Zhang K, Ju S, Olek DJ Jr, Schwartz L, Keng PC, Howell R, Zhang L, Okunieff P (2011) Antioxidant properties of quercetin. Adv Exp Med Biol 701:283–289CrossRefGoogle Scholar
  36. 36.
    Camargo CA, da Silva ME, da Silva RA, Justo GZ, Gomes-Marcondes MC, Aoyama H (2011) Inhibition of tumor growth by quercetin with increase of survival and prevention of cachexia in Walker 256 tumor-bearing rats. Biochem Biophys Res Commun 406:638–642CrossRefGoogle Scholar
  37. 37.
    Hsieh TC, Wu JM (2009) Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res 29:4025–4032Google Scholar
  38. 38.
    Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, Yang Y (2009) The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials 30:4743–4751CrossRefGoogle Scholar
  39. 39.
    Horvathova K, Novotny L, Tothova D, Vachalkova A (2004) Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma 51:395–399Google Scholar
  40. 40.
    Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S, Nair MG (2006) From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Oncol Endocr Metab 10:87–118Google Scholar
  41. 41.
    Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B, Cseh J, Mikolas E, Szijarto IA, Merei A, Halmai R, Meszaros LG, Sumegi B, Wittmann I (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106:383–389CrossRefGoogle Scholar
  42. 42.
    Takahiro N, Takaaki Y, Joji U, Keisuke O (2003) Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol Pharm Bull 26:474–480CrossRefGoogle Scholar
  43. 43.
    Ono K, Hirohata M, Yamada M (2005) Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro. Biochem Biophys Res Commun 336:444–449CrossRefGoogle Scholar
  44. 44.
    Mathew S, Abraham TE (2004) Ferulic acid: an antioxidant found naturally in plant cell walls and feruloyl esterases involved in its release and their applications. Crit Rev Biotechnol 24:59–83CrossRefGoogle Scholar
  45. 45.
    Sri Balasubashini M, Rukkumani R, Menon VP (2003) Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol 40:118–122CrossRefGoogle Scholar
  46. 46.
    Takeda H, Tsuji M, Miyamoto J, Masuya J, Iimori M, Matsumiya T (2003) Caffeic acid produces antidepressive- and/or anxiolytic-like effects through indirect modulation of the alpha 1A-adrenoceptor system in mice. Neuroreport 14:1067–1070Google Scholar
  47. 47.
    Lotitoa SB, Fraga CG (2000) Catechins delay lipid oxidation and α-tocopherol and β-carotene depletion following ascorbate depletion in human plasma. Exp Biol Med 225:32–38CrossRefGoogle Scholar
  48. 48.
    Patel JM (2008) A review of potential health benefits of flavonoids. Lethbridge Undergrad Res J 3:2Google Scholar
  49. 49.
    Kinsella JE, Frankel E, German B, Kanner J (1993) Possible mechanisms for the protective role of antioxidants in wine and plant foods. Food Technol 47:85–89Google Scholar
  50. 50.
    Lin YG, Kunnumakkara AB, Nair A et al (2007) Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor kB pathway. Clin Cancer Res 13:3423–3430CrossRefGoogle Scholar
  51. 51.
    Waffo-Teguo P, Krisa S, Richard T, Merillon JM (2008) Grapevine stilbenes and their biological effects. In: Ramawat KG, Mérillon J-M (eds) Bioactive molecules and medicinal plants. Springer, Berlin/Heidelberg, p 25CrossRefGoogle Scholar
  52. 52.
    Espin JC, Garcia-Conesa MT, Tomas-Barberan FA (2007) Nutraceuticals: facts and fiction. Phytochemistry 68:2986–3008CrossRefGoogle Scholar
  53. 53.
    Ziberna L, Lunder M, Moze S, Vanzo A, Tramer F, Passamonti S, Drevensek G (2010) Acute cardioprotective and cardiotoxic effects of bilberry anthocyanins in ischemia–reperfusion injury: beyond concentration-dependent antioxidant activity. Cardiovasc Toxicol 10:283–294CrossRefGoogle Scholar
  54. 54.
    Juranic Z, Zizak Z (2005) Biological activities of Berries: from antioxidant capacity to anti-cancer effects. Biofactors 23:207–211CrossRefGoogle Scholar
  55. 55.
    Karlsen A, Retterstol L, Laake P, Paur I, Kjolsrud-Bohn S, Sandvik L, Blomhoff R (2007) Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 137:1951–1954Google Scholar
  56. 56.
    Williamson G, Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II Review of 93 intervention studies. Am J Clin Nutr 81:243S–255SGoogle Scholar
  57. 57.
    Kang NJ, Shin SH, Lee HJ, Lee KW (2011) Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther 130:310–324CrossRefGoogle Scholar
  58. 58.
    Howes LG, Howes JB, Knight DC (2006) Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 55:203–211CrossRefGoogle Scholar
  59. 59.
    Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM (2007) Isoflavone treatment for acute menopausal symptoms. Menopause 14:468–473CrossRefGoogle Scholar
  60. 60.
    Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83:1118–1125Google Scholar
  61. 61.
    Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408Google Scholar
  62. 62.
    Morris B (2008) How xenohormetic compounds confer health benefits. In: Le Bourg E, Rattan SIS (eds) Mild stress and healthy aging: applying hormesis in aging research and interventions. Springer, DordrechtGoogle Scholar
  63. 63.
    Lamming DW, Wood JG, Sinclair DA (2004) Small molecules that regulate lifespan: evidence for xenohormesis (review). Mol Microbiol 53:1003–1009CrossRefGoogle Scholar
  64. 64.
    Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196CrossRefGoogle Scholar
  65. 65.
    Szewczuk LM, Forti L, Stivala LA, Penning TM (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem 279:22727–22737CrossRefGoogle Scholar
  66. 66.
    Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur DG, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342CrossRefGoogle Scholar
  67. 67.
    Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127:1109–1122CrossRefGoogle Scholar
  68. 68.
    Cornelli U (2009) Antioxidant use in nutraceuticals. Clin Dermatol 27:175–194CrossRefGoogle Scholar
  69. 69.
    Food and Nutrition Board, Institute of Medicine (2002) Dietary reference intakes. National Academy Press, Washington, DCGoogle Scholar
  70. 70.
    Rijk MC, Breteler MMB, Breeijen JH et al (1997) Dietary antioxidants and parkinsons disease, the Rotterdam study. Arch Neurol 54:762CrossRefGoogle Scholar
  71. 71.
    Ferrari CKB (2001) Oxidative stress pathophysiology: searching for an effective antioxidant protection. Int Med J 8:175–184Google Scholar
  72. 72.
    Youdim KA, Joseph JA (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30:583–594CrossRefGoogle Scholar
  73. 73.
    Bates CJ, Benton D, Biesalski HK, Staehelin HB, van Staveren W et al (2002) Nutrition and aging: a consensus statement. J Nutr Health Aging 6:103–116Google Scholar
  74. 74.
    Childs N, Hasler C, Pike L, Shahidi F, Watkins B (2003) Nutraceuticals for health promotion and disease prevention. Council for Agricultural Science and Technology, IA, USAGoogle Scholar
  75. 75.
    Chang J (2000) Medicinal herbs: drugs or dietary supplements? Biochem Pharmacol 59:211–219CrossRefGoogle Scholar
  76. 76.
    Halt M (1998) Moulds and mycotoxins in herb tea and medicinal plants. Eur J Epidemiol 14:269–274CrossRefGoogle Scholar
  77. 77.
    Rajani M, Kanaki NS (2008) Phytochemical standardization of herbal drugs and polyherbal formulations. In: Ramawat KG, Merillon JM (eds) Bioactive molecules and medicinal plants. Springer, Berlin/HeidelbergGoogle Scholar
  78. 78.
    Nortier JL, Martinez MC, Schemeiser HH et al (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342:1686–1692CrossRefGoogle Scholar
  79. 79.
    Ernst E (2001) Functional foods, nutraceuticals, designer foods: innocent fad or counterprotective marketing ploy? Eur J Clin Pharmacol 57:353–355CrossRefGoogle Scholar
  80. 80.
    Dev R, Kumar S, Singh J, Chauhan B (2011) Potential role of nutraceuticals in present scenerio: a review. J Appl Pharm Sci 1:26–28Google Scholar
  81. 81.
    Tank DS, Gandhi S, Shah M (2010) Nutraceuticals – portmanteau of science and nature. Int J Pharm Sci Rev Res 5:33–38Google Scholar
  82. 82.
    Chaturvedi S, Sharma PK, Garg VK, Bansal M (2011) Role of nutraceuticals in health promotion. Int J Pharm Technol Res 3:442–448Google Scholar
  83. 83.
  84. 84.

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Laboratory of Bio-Molecular Technology, Department of BotanyM. L. Sukhadia UniversityUdaipurIndia

Personalised recommendations